ESMOLOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Esmolol, and when can generic versions of Esmolol launch?
Esmolol is a drug marketed by Am Regent, Amneal, Eugia Pharma, Fresenius Kabi Usa, Gland, Hikma, Hq Spclt Pharma, Mylan Institutional, Mylan Labs Ltd, and Sagent Pharms Inc. and is included in twelve NDAs. There are two patents protecting this drug.
The generic ingredient in ESMOLOL is esmolol hydrochloride. There are eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the esmolol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Esmolol
A generic version of ESMOLOL was approved as esmolol hydrochloride by HIKMA on August 10th, 2004.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ESMOLOL?
- What are the global sales for ESMOLOL?
- What is Average Wholesale Price for ESMOLOL?
Summary for ESMOLOL
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 12 |
| Drug Prices: | Drug price information for ESMOLOL |
| What excipients (inactive ingredients) are in ESMOLOL? | ESMOLOL excipients list |
| DailyMed Link: | ESMOLOL at DailyMed |
US Patents and Regulatory Information for ESMOLOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Am Regent | ESMOLOL HYDROCHLORIDE | esmolol hydrochloride | INJECTABLE;INJECTION | 201126-001 | Feb 20, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hq Spclt Pharma | ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER | esmolol hydrochloride | SOLUTION;INTRAVENOUS | 205703-002 | Apr 7, 2016 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Fresenius Kabi Usa | ESMOLOL HYDROCHLORIDE | esmolol hydrochloride | INJECTABLE;INJECTION | 076573-001 | May 2, 2005 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
